Today, Definitive Health announced its acquisition of PatientFinder, a software analytics firm that concentrates on identifying patient clusters.

KRANTZ: The PatientFinder acquisition allows us to put a new analytical front-end on our best-in-class data surrounding providers and the claims within the patients that they serve.

From a client perspective, this allows our clients to quickly analyze claims data and find very specific patient cohorts so that they’re able to find patients with certain combinations of procedures, diagnoses, and drug histories.

What PatientFinder allows our clients to do is to analyze and make sense that data far more quickly so that they can improve patient care and identify patients that would benefit from new, innovative drugs and medical devices.

Definitive Healthcare’s “Connect-the-dots” platform is designed to help clients “Solve their most critical revenue generating objectives,” through analyzing “Referral patterns, patient leakage trends, total and average charges, patient outcomes and population health trends to drive a complete end-to-end commercialization effort.” While this may help improve administrative, clinical and financial performance between providers and payers, I don’t see how the third tier of the healthcare triangle fits in.

If these life sciences companies have a new technology platform and are trying to identify which disease categories would be most effective and cost effective for them to serve, PatientFinder allows them to quickly size those markets, identify how many patients potentially would benefit, where those patients are, and how to reach them.

CohortBuilder, if you zoom out, is ultimately for anyone selling healthcare products and services to a patient population that’s less than “All of the patients in the world.” Providers are most definitely included in that.